Dossier
weight-loss drug orders
Coverage of weight-loss drug orders in the Nexus archive.
- Wall Street funds back China’s WuXi AppTec as weight-loss drug orders soar
US global asset managers, including BlackRock, have increased stakes in China's WuXi AppTec, anticipating higher earnings from a surge in weight-loss drug manufacturing orders. Investors show growing interest in China’s contract development and manufacturing organizations and biotechnology sectors, as noted by HSBC's Linda Shu.